Entecavir

Form: Tablet

Strength: 0.5 mg, 1 mg

Reference Brands: Baraclude® (EU & US)

Category: Hepatitis

Entecavir Tablets (Baraclude® generic) are oral antivirals used to treat chronic hepatitis B infections. Available in 0.5 mg and 1 mg strengths, they inhibit HBV polymerase to reduce viral replication. Manufactured under EU-GMP and USFDA-certified facilities, Entecavir is offered for B2B supply, licensing, and government tenders. The product comes with full CTD dossiers, stability data, and regulatory support. Widely accepted in the US and EU markets, Entecavir is a key product for public health tenders and antiviral portfolios focused on hepatitis B control programs.